Masked polycythemia vera diagnosed according to WHO and BCSH classification

American Journal of Hematology

Volumn 89, Issue 2, 2014, Pages 199-202

  Barbui, Tiziano ^a   Thiele, Jürgen ^b   Carobbio, Alessandra ^a   Gisslinger, Heinz ^c   Finazzi, Guido ^a   Rumi, Elisa ^d   Luigia Randi, Maria ^e   Vannucchi, Alessandro M ^f   Gisslinger, Bettina ^c   Müllauer, Leonhard ^c   Ruggeri, Marco ^g   Rambaldi, Alessandro ^a   Tefferi, Ayalew ^h  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^b UNIVERSITY OF COLOGNE   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g SAN BORTOLO HOSPITAL   (Italy)

^h MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RETICULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE MARROW; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; FIBROSIS; GENE MUTATION; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORPHOLOGY; MYELOPROLIFERATIVE DISORDER; OVERALL SURVIVAL; POLYCYTHEMIA VERA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; THROMBOCYTE COUNT; VERY ELDERLY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; ERYTHROCYTE INDICES; EXONS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; POLYCYTHEMIA VERA; RISK FACTORS; YOUNG ADULT;

EID: 84893964717     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23617     Document Type: Article

References (15)

1. McMullin MF, Bareford D, Campbell P, et al. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol 2005;130:174-195.
2. McMullin MF, Reilly JT, Campbell P, et al. Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis. Br J Haematol 2007;138:821-822.
3. McMullin MF. The classification and diagnosis of erythrocytosis. Int J Lab Hemtol 2008;30:447-459.
4. Thiele J, Kvasnicka HM, Orazi A, et al. Polycythaemia vera. In: Swerdlow S, Campo E, Harris N, et al., editors. WHO Classification of Tumours of Haematopoietic and Lympoid Tissues. Lyon, France: IARC Press; 2008. pp 40-43.
5. Johansson PL, Safai-Kutti S, Kutti J. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: A study of patients with polycythemia vera and apparent polycythaemia. Br J Haematol 2005;129:701-705.
6. Spivak JL, Silver RT. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: An alternative proposal. Blood 2008;112:231-239.
7. Alvarez-Larran A, Anchocea A, Angona A, et al. Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia. Haematologica 2012;97:1704-1707.
8. Silver RT, Chow W, Orazi A, et al. Evaluation of WHO criteria for diagnosis of polycythemia vera: A prospective analysis. Blood 2013;122:1881-1886.
9. Barbui T, Thiele J, Carobbio A, et al. Masked polycythemia vera diagnosed according to WHO and BCSH classification. Am J Hematol., 2013 Oct 26. doi: 10.1002/ajh.23617. [Epub ahead of print].
10. Ellis JT, Peterson P, Geller SA, Rappaport H. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol 1986;23:144-115.
11. Thiele J, Kvasnicka HM. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV). Histol Histopathol 2005;20:317-328.
12. Georgii A, Buesche G, Kreft A. The histopathology of chronic myeloproliferative diseases. Baillieres Clin Haematol 1998;11:721-749.
13. Thiele J, Kvasnicka HM, Diehl V. Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia. Acta Haematol 2005;113:213-219.
14. Gianelli U, Iurlo A, Vener C, et al. The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia. Am J Clin Pathol 2008;30:336-342.
15. Kvasnicka HM, Thiele J. Prodromal myeloproliferative neoplasms: The 2008 WHO classification. Am J Hematol 2010;85:62-66.